Individual investors in Assembly Biosciences, Inc. (NASDAQ:ASMB) are its biggest bettors, and their bets paid off as stock gained 14% last week

21 investors collectively own 50% majority stake in Assembly Biosciences, Inc. Individual investors hold the largest share, followed by institutional investors and hedge funds. The company's largest shareholder is Gilead Sciences, Inc. with 20% ownership. Insider ownership is valued at $13m.